NYSE CRTR Economy Event Watch the replay →

Advertisement
Advertisement

ARKGvsPSCHETF Comparison

ETF 1
ARKG

ARK Genomic Revolution ETF

This fund is part of
BioTech & Genomics
-0.39%
VS
ETF 2
PSCH

Invesco S&P SmallCap Health Care ETF

This fund is part of
US Health Care
-0%

ARK Genomic Revolution ETF (ARKG) belongs to the BioTech & Genomics segment. Invesco S&P SmallCap Health Care ETF (PSCH) is part of the US Health Care segment. ARKG's top 3 sector exposures are Health Care and Information Technology. In contrast, PSCH's top sector exposures are Health Care  ARKG is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.29% for PSCH. ARKG is up 14.68% year-to-date (YTD) with -$93M in YTD flows. PSCH performs worse with 8.5% YTD performance, and -$17M in YTD flows. Run a side-by-side ETF comparison of ARKG and PSCH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

ARKG vs PSCH performance and flow charts

Performance

-505101520%May 12May 19May 26Jun 2Jun 9

Cumulative Flows

-60,000,000-40,000,000-20,000,0000May 12May 19May 26Jun 2Jun 9

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 06/12/2026
1M3MYTD1Y3Y5Y
Perf.
ARKG
PSCH
+12.70%+6.00%
+27.93%+19.98%
+14.68%+8.50%
+41.38%+16.31%
-2.11%+8.09%
-61.48%-24.67%
Flows
ARKG
PSCH
-$66M+$492K
-$83M-$3M
-$93M-$17M
-$80M-$27M
-$636M-$150M
-$2.66B-$235M
Volatility and drawdown
3M1Y3Y5Y
Volatility
ARKG
PSCH
+45.22%+21.44%
+41.97%+20.54%
+43.21%+21.72%
+45.71%+22.89%
Max drawdown
ARKG
PSCH
-10.02%-4.51%
-27.52%-15.36%
-51.98%-22.80%
-80.16%-47.23%
Max drawdown duration
ARKG
PSCH
35d13d
126d168d
1059d478d
1809d1811d
Trading data

Create an account to view trading data

Join for free
ARKG
PSCH
Last sale
6/15/2026 at 1:30 PM
$35.10
$48.07
Previous close
06/12/2026
$33.47
$47.79
Consolidated volume
06/12/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of May 29, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

ARKG
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
ARKG
PSCH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 6/15/2026 at 1:30 PM
Live
Closed
ARKG
PSCH
Last price
$35.10
$48.07
1D performance
+4.87%
+0.58%
AuM$1.24 B$140.15 M
E/R0.75%0.29%
Characteristics
ARKG
PSCH
Management strategyActivePassive
ProviderArk InvestmentInvesco
Benchmark-S&P SmallCap 600 Capped Health Care Index
N° of holdings2771
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateApril 2, 2019April 7, 2010
ESGNoNo
Advertisement
Exposure

Countries

ARKG
USA
68.62%
Switzerland
8.97%
Other
22.41%
PSCH
USA
96.15%
Other
3.85%

Sectors

ARKG
Health Care
76.57%
Other
23.43%
PSCH
Health Care
90.67%
Other
9.33%

Diversification

ARKG

Total weight of top 15 holdings out of 15

60.37%
PSCH

Total weight of top 15 holdings out of 15

44.63%

Top 15 holdings

Data as of April 30, 2026
ARKG
CRISPR THERAPEUTICS
8.97%
10X GENOMICS INC
5.66%
BEAM THERAPEUTICS
5.54%
ABSCI
4.73%
ILLUMINA
4.08%
NATERA
4.00%
PERSONALIS INC
3.61%
CAREDX INC/D
3.61%
RECURSION PHARMACEUTICALS
3.51%
INTELLIA THERAPEUTICS INC
3.40%
GUARDANT HEALTH INC
3.38%
VERACYTE INC/D
2.74%
ADAPTIVE BIOTECHNOLOGIES
2.44%
NURIX THERAPEUTICS
2.41%
COMPASS PATHWAYS ADR
2.29%
PSCH
MOLINA HLTHCRE
4.96%
KRYSTAL BIOTECH INC
3.79%
GLAUKOS
3.77%
US10950A1060
3.46%
TELEFLEX
3.21%
PROTAGONIST THERAPEUTICS INC
3.11%
ALKERMES
3.00%
PTC THERAPEUTI/D
2.99%
TG THERAPEUTICS
2.59%
LIGAND PHARMACEUTICALS
2.56%
CORCEPT THERAPEUTICS
2.33%
US45579U1097
2.30%
APELLIS PHARMACEUTICALS
2.26%
RADNET
2.16%
MERIT MEDICAL SYSTEMS
2.15%
Frequently asked questions about ARKG and PSCH

How have the ARKG and PSCH ETFs performed in 2026?

As of June 12, 2026, ARKG is up 14.68% year-to-date (YTD), while PSCH has returned 8.5%. That puts ARKG better performer ahead so far this year.

Which ETF is attracting more investor money: ARKG or PSCH?

Year-to-date, the ARKG ETF saw -$93M in flows, compared to -$17M for PSCH.

Which ETF is more volatile: ARKG or PSCH?

Over the past year, ARKG had a volatility of 41.97%, while PSCH experienced 20.54%.

Which ETF is bigger: ARKG or PSCH?

As of June 12, 2026, ARKG holds $1.24 B in assets under management (AUM), while PSCH manages $140.15 M.

What sectors do the ARKG and PSCH ETFs invest in?

ARKG leans toward sectors like Health Care. Meanwhile, PSCH focuses on Health Care.

What are the top holdings of the ARKG ETF and PSCH ETF?

ARKG top holdings include CRISPR THERAPEUTICS, 10X GENOMICS INC and BEAM THERAPEUTICS. PSCH holds in its top three: MOLINA HLTHCRE, KRYSTAL BIOTECH INC and GLAUKOS.

Which ETF is more diversified: ARKG or PSCH?

ARKG holds 27 securities with 60.37% of its assets in the top 15. PSCH has 75 securities and a top 15 weight of 44.63%.

Advertisement
Latest news about ARKG & PSCH
Advertisement
Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder